Literature DB >> 4007039

Salicylate protein binding in serum from young and elderly subjects as measured by diafiltration.

L J Lesko, P K Narang, L Yeager, N R Cutler.   

Abstract

The protein binding of salicylate was measured by continuous ultrafiltration (diafiltration) at 22 degrees C in serum obtained from 5 healthy young (mean age: 27 years) and 5 healthy elderly (mean age: 73 years) male volunteers. Unbound salicylate increased disproportionately with increasing total salicylate concentration, up to 7000 mumol, in all sera. The fraction bound of salicylate was significantly lower in sera from elderly but this was not due to decreased albumin or total protein concentrations. The binding of salicylate to serum proteins was characterized by two classes of binding sites. The high affinity site had an association constant of either 9490 l/mol (young) or 7560 l/mol (elderly) and the number of binding sites was either 4.7 (young) or 3.7 (elderly). The total binding capacity of the low affinity site, 112 l/mol, in sera from elderly was significantly less than the binding capacity, 631 l/mol, in sera from young. Differences in binding capacity of the low affinity site partially accounted for a two to three-fold increase in the salicylate free fraction in elderly sera. These data suggest that age-related differences in serum protein binding may influence salicylate pharmacokinetics.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4007039     DOI: 10.1007/bf00543334

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  31 in total

1.  Protein binding of salicylate in uremic and normal plasma.

Authors:  O Borgå; I O Cederlöf; V A Ringberger; A Norlin
Journal:  Clin Pharmacol Ther       Date:  1976-10       Impact factor: 6.875

2.  Factors affecting drug binding in plasma of elderly patients.

Authors:  S Wallace; B Whiting
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

3.  Role of concentration-dependent plasma protein binding in disopyramide disposition.

Authors:  P J Meffin; E W Robert; R A Winkle; S Harapat; F A Peters; D C Harrison
Journal:  J Pharmacokinet Biopharm       Date:  1979-02

4.  Tolbutamide binding to plasma proteins of young and old human subjects.

Authors:  A K Miller; J Adir; R E Vestal
Journal:  J Pharm Sci       Date:  1978-08       Impact factor: 3.534

5.  Importance of protein binding for the interpretation of serum or plasma drug concentrations.

Authors:  D J Greenblatt; E M Sellers; J Koch-Weser
Journal:  J Clin Pharmacol       Date:  1982 May-Jun       Impact factor: 3.126

6.  Pharmacokinetics of salicylate elimination in man.

Authors:  G Levy
Journal:  J Pharm Sci       Date:  1965-07       Impact factor: 3.534

7.  Theoretical analysis of the binding of salicylate by human serum albumin: the relationship between free and bound drug and therapeutic levels.

Authors:  W D Wosilait
Journal:  Eur J Clin Pharmacol       Date:  1976-02-06       Impact factor: 2.953

8.  Free versus bound salicylate concentration in adults and children with chronic inflammatory joint disease: serum albumin and other potential factors affecting the levels.

Authors:  P B Costello; F A Green; C Y Jung
Journal:  Arthritis Rheum       Date:  1982-01

9.  Protein binding of salicylate in cutaneous hepatic porphyria.

Authors:  W H Steele; S W Boobis; M R Moore; A Goldberg; M J Brodie; D J Summer
Journal:  Eur J Clin Pharmacol       Date:  1978-06-19       Impact factor: 2.953

Review 10.  Drug therapy in the elderly.

Authors:  J G Ouslander
Journal:  Ann Intern Med       Date:  1981-12       Impact factor: 25.391

View more
  5 in total

Review 1.  Age-related changes in protein binding of drugs: implications for therapy.

Authors:  M K Grandison; F D Boudinot
Journal:  Clin Pharmacokinet       Date:  2000-03       Impact factor: 6.447

Review 2.  Plasma protein binding of drugs in the elderly.

Authors:  S M Wallace; R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1987-01       Impact factor: 6.447

Review 3.  Salicylate intoxication in the elderly. Recognition and recommendations on how to prevent it.

Authors:  C Durnas; B J Cusack
Journal:  Drugs Aging       Date:  1992 Jan-Feb       Impact factor: 3.923

4.  Salicylate pharmacokinetics in patients with rheumatoid arthritis.

Authors:  S G Owen; M S Roberts; W T Friesen; H W Francis
Journal:  Br J Clin Pharmacol       Date:  1989-10       Impact factor: 4.335

5.  Influence of gender and oral contraceptive steroids on the metabolism of salicylic acid and acetylsalicylic acid.

Authors:  J O Miners; N Grgurinovich; A G Whitehead; R A Robson; D J Birkett
Journal:  Br J Clin Pharmacol       Date:  1986-08       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.